| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | disorganized sperm mitochondrial sheath | 1.80e-05 | 10 | 76 | 3 | MP:0014468 | |
| Domain | ARM-type_fold | 8.76e-06 | 339 | 95 | 10 | IPR016024 | |
| Domain | - | 3.76e-05 | 321 | 95 | 9 | 3.80.10.10 | |
| Domain | L_dom-like | 4.45e-05 | 328 | 95 | 9 | IPR032675 | |
| Domain | Leu-rich_rpt | 7.24e-05 | 271 | 95 | 8 | IPR001611 | |
| Domain | CHD_N | 7.65e-05 | 3 | 95 | 2 | IPR012958 | |
| Domain | CHD_C2 | 7.65e-05 | 3 | 95 | 2 | IPR012957 | |
| Domain | CHDCT2 | 7.65e-05 | 3 | 95 | 2 | PF08074 | |
| Domain | CHDNT | 7.65e-05 | 3 | 95 | 2 | PF08073 | |
| Domain | DUF1086 | 7.65e-05 | 3 | 95 | 2 | IPR009462 | |
| Domain | DUF1087 | 7.65e-05 | 3 | 95 | 2 | IPR009463 | |
| Domain | DUF1087 | 7.65e-05 | 3 | 95 | 2 | PF06465 | |
| Domain | DUF1086 | 7.65e-05 | 3 | 95 | 2 | PF06461 | |
| Domain | DUF1087 | 7.65e-05 | 3 | 95 | 2 | SM01147 | |
| Domain | DUF1086 | 7.65e-05 | 3 | 95 | 2 | SM01146 | |
| Domain | LRRNT | 1.52e-04 | 53 | 95 | 4 | PF01462 | |
| Domain | ARM-like | 4.57e-04 | 270 | 95 | 7 | IPR011989 | |
| Domain | LRR | 5.66e-04 | 201 | 95 | 6 | PS51450 | |
| Domain | LRAT | 7.03e-04 | 8 | 95 | 2 | PF04970 | |
| Domain | LRAT-like_dom | 7.03e-04 | 8 | 95 | 2 | IPR007053 | |
| Domain | Cys-rich_flank_reg_C | 1.15e-03 | 90 | 95 | 4 | IPR000483 | |
| Domain | LRRCT | 1.15e-03 | 90 | 95 | 4 | SM00082 | |
| Domain | LRRNT | 1.57e-03 | 98 | 95 | 4 | IPR000372 | |
| Domain | LRRNT | 1.57e-03 | 98 | 95 | 4 | SM00013 | |
| Domain | LRR_8 | 1.81e-03 | 171 | 95 | 5 | PF13855 | |
| Domain | FN_type2_col-bd | 2.24e-03 | 14 | 95 | 2 | IPR000562 | |
| Domain | FN2_2 | 2.24e-03 | 14 | 95 | 2 | PS51092 | |
| Domain | FN2_1 | 2.24e-03 | 14 | 95 | 2 | PS00023 | |
| Domain | fn2 | 2.24e-03 | 14 | 95 | 2 | PF00040 | |
| Domain | FN2 | 2.24e-03 | 14 | 95 | 2 | SM00059 | |
| Domain | Ubiquitin-rel_dom | 2.49e-03 | 184 | 95 | 5 | IPR029071 | |
| Domain | - | 2.93e-03 | 16 | 95 | 2 | 1.10.506.10 | |
| Domain | RasGAP_dom | 3.71e-03 | 18 | 95 | 2 | IPR001936 | |
| Pubmed | EXOSC10 CCDC30 KIF1B APOB CHD4 ANKRD50 PTPN3 SEC24D PDS5A AFDN DCLRE1A SCLT1 CLEC16A | 2.93e-07 | 777 | 98 | 13 | 35844135 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 7.86e-06 | 2 | 98 | 2 | 7560064 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7575689 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23983103 | ||
| Pubmed | Delayed onset of inherited ALS by deletion of the BDNF receptor TrkB.T1 is non-cell autonomous. | 7.86e-06 | 2 | 98 | 2 | 33359475 | |
| Pubmed | MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells. | 7.86e-06 | 2 | 98 | 2 | 30066929 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 35840571 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 7.86e-06 | 2 | 98 | 2 | 35568926 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 7.86e-06 | 2 | 98 | 2 | 8843877 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | INTS7 CIP2A AHCTF1 SLC43A1 USP24 URB2 XPO1 PLXNB2 RINT1 CEP78 PDS5A IQGAP3 | 1.40e-05 | 942 | 98 | 12 | 31073040 |
| Pubmed | 1.62e-05 | 653 | 98 | 10 | 22586326 | ||
| Pubmed | 1.97e-05 | 195 | 98 | 6 | 19454010 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 28692064 | ||
| Pubmed | Sweat gland development requires an eccrine dermal niche and couples two epidermal programs. | 2.35e-05 | 3 | 98 | 2 | 38096824 | |
| Pubmed | Plexin-B2 controls the timing of differentiation and the motility of cerebellar granule neurons. | 2.35e-05 | 3 | 98 | 2 | 34100719 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 32658897 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 30133147 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 33036707 | ||
| Pubmed | 2.41e-05 | 202 | 98 | 6 | 24639526 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.06e-05 | 582 | 98 | 9 | 20467437 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 16574654 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 9326634 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 25633318 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 28935709 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.76e-05 | 774 | 98 | 10 | 15302935 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 7.53e-05 | 248 | 98 | 6 | 27926873 | |
| Pubmed | Protocadherin 12 (VE-cadherin 2) is expressed in endothelial, trophoblast, and mesangial cells. | 7.82e-05 | 5 | 98 | 2 | 15541725 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 34395414 | ||
| Pubmed | 9.21e-05 | 31 | 98 | 3 | 27798109 | ||
| Pubmed | 1.11e-04 | 33 | 98 | 3 | 30917309 | ||
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 25893857 | ||
| Pubmed | Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity. | 1.17e-04 | 6 | 98 | 2 | 17626165 | |
| Pubmed | 1.52e-04 | 282 | 98 | 6 | 23667531 | ||
| Pubmed | The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export. | 1.64e-04 | 7 | 98 | 2 | 17234882 | |
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 12915301 | ||
| Pubmed | 1.79e-04 | 708 | 98 | 9 | 39231216 | ||
| Pubmed | 1.86e-04 | 418 | 98 | 7 | 34709266 | ||
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 24616052 | ||
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 2.18e-04 | 8 | 98 | 2 | 10655032 | |
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 19488044 | ||
| Pubmed | SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. | 2.18e-04 | 8 | 98 | 2 | 23580231 | |
| Pubmed | Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. | 2.18e-04 | 8 | 98 | 2 | 27365365 | |
| Pubmed | Cyclin D1 promotes neurogenesis in the developing spinal cord in a cell cycle-independent manner. | 2.18e-04 | 8 | 98 | 2 | 21709239 | |
| Pubmed | Understanding the Significance of the Hypothalamic Nature of the Subthalamic Nucleus. | 2.18e-04 | 8 | 98 | 2 | 34518367 | |
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 23840823 | ||
| Pubmed | 2.79e-04 | 9 | 98 | 2 | 20357111 | ||
| Pubmed | 2.79e-04 | 9 | 98 | 2 | 10482235 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.99e-04 | 759 | 98 | 9 | 35915203 | |
| Pubmed | 3.12e-04 | 603 | 98 | 8 | 11181995 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 3.37e-04 | 211 | 98 | 5 | 17314511 | |
| Pubmed | V1 spinal neurons regulate the speed of vertebrate locomotor outputs. | 3.48e-04 | 10 | 98 | 2 | 16525473 | |
| Pubmed | Stringent specificity in the construction of a GABAergic presynaptic inhibitory circuit. | 3.48e-04 | 10 | 98 | 2 | 19804761 | |
| Pubmed | Sororin mediates sister chromatid cohesion by antagonizing Wapl. | 3.48e-04 | 10 | 98 | 2 | 21111234 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 3.59e-04 | 331 | 98 | 6 | 19490893 | |
| Pubmed | 3.64e-04 | 332 | 98 | 6 | 37433992 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.64e-04 | 332 | 98 | 6 | 32786267 | |
| Pubmed | 4.25e-04 | 11 | 98 | 2 | 17492640 | ||
| Pubmed | Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool. | 4.25e-04 | 11 | 98 | 2 | 28800615 | |
| Pubmed | 4.25e-04 | 11 | 98 | 2 | 24348274 | ||
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 4.25e-04 | 11 | 98 | 2 | 10204490 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 4.34e-04 | 52 | 98 | 3 | 24613359 | |
| Pubmed | 4.54e-04 | 638 | 98 | 8 | 33239621 | ||
| Pubmed | 5.09e-04 | 12 | 98 | 2 | 9885572 | ||
| Pubmed | Genetic and physical mapping of the biglycan gene on the mouse X chromosome. | 5.09e-04 | 12 | 98 | 2 | 8093671 | |
| Pubmed | 5.09e-04 | 12 | 98 | 2 | 16020526 | ||
| Pubmed | Afadin Signaling at the Spinal Neuroepithelium Regulates Central Canal Formation and Gait Selection. | 5.09e-04 | 12 | 98 | 2 | 32521266 | |
| Pubmed | 5.09e-04 | 12 | 98 | 2 | 22560079 | ||
| Pubmed | IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. | 5.09e-04 | 12 | 98 | 2 | 18604197 | |
| Pubmed | ZC4H2 stabilizes RNF220 to pattern ventral spinal cord through modulating Shh/Gli signaling. | 5.09e-04 | 12 | 98 | 2 | 31336385 | |
| Pubmed | 5.13e-04 | 650 | 98 | 8 | 38777146 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 5.27e-04 | 497 | 98 | 7 | 36774506 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 5.40e-04 | 56 | 98 | 3 | 26919559 | |
| Pubmed | 5.59e-04 | 133 | 98 | 4 | 15144186 | ||
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 5.98e-04 | 58 | 98 | 3 | 12852856 | |
| Pubmed | LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. | 6.01e-04 | 13 | 98 | 2 | 19703393 | |
| Pubmed | 6.01e-04 | 13 | 98 | 2 | 15576403 | ||
| Pubmed | Ftm is a novel basal body protein of cilia involved in Shh signalling. | 6.01e-04 | 13 | 98 | 2 | 17553904 | |
| Pubmed | 6.01e-04 | 13 | 98 | 2 | 24698273 | ||
| Pubmed | The structural biology of HIV-1: mechanistic and therapeutic insights. | 6.01e-04 | 13 | 98 | 2 | 22421880 | |
| Pubmed | 6.01e-04 | 13 | 98 | 2 | 22115757 | ||
| Pubmed | 6.01e-04 | 13 | 98 | 2 | 18172165 | ||
| Pubmed | 6.01e-04 | 13 | 98 | 2 | 25648896 | ||
| Pubmed | 6.53e-04 | 371 | 98 | 6 | 25241761 | ||
| Pubmed | 6.61e-04 | 60 | 98 | 3 | 32027825 | ||
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 33305180 | ||
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 17360773 | ||
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 16428440 | ||
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 10981960 | ||
| Pubmed | Notch and MAML signaling drives Scl-dependent interneuron diversity in the spinal cord. | 7.00e-04 | 14 | 98 | 2 | 17359917 | |
| Pubmed | Erythro-myeloid progenitors contribute endothelial cells to blood vessels. | 7.00e-04 | 14 | 98 | 2 | 30258231 | |
| Pubmed | NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. | 7.00e-04 | 14 | 98 | 2 | 25150861 | |
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 19797899 | ||
| Pubmed | Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure. | 7.00e-04 | 14 | 98 | 2 | 26680198 | |
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 19666821 | ||
| Pubmed | 7.00e-04 | 14 | 98 | 2 | 20585571 | ||
| Pubmed | 7.93e-04 | 146 | 98 | 4 | 21399614 | ||
| Pubmed | 8.06e-04 | 15 | 98 | 2 | 10679268 | ||
| Pubmed | 8.06e-04 | 15 | 98 | 2 | 23900540 | ||
| Pubmed | 8.06e-04 | 15 | 98 | 2 | 23418536 | ||
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 8.06e-04 | 15 | 98 | 2 | 35695185 | |
| GeneFamily | C-type lectin domain family | 5.86e-04 | 47 | 63 | 3 | 494 | |
| GeneFamily | PHD finger proteins|NuRD complex | 7.71e-04 | 12 | 63 | 2 | 1305 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.46e-03 | 394 | 63 | 6 | 471 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.74e-07 | 197 | 98 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 2.83e-07 | 198 | 98 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-06 | 163 | 98 | 6 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 169 | 98 | 6 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 181 | 98 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 187 | 98 | 6 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.78e-06 | 196 | 98 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 5.21e-06 | 199 | 98 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.36e-06 | 200 | 98 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.36e-06 | 200 | 98 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.78e-05 | 160 | 98 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.86e-05 | 161 | 98 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 162 | 98 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.31e-05 | 166 | 98 | 5 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.61e-05 | 169 | 98 | 5 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-05 | 169 | 98 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 175 | 98 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-05 | 175 | 98 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.38e-05 | 176 | 98 | 5 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.62e-05 | 178 | 98 | 5 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.62e-05 | 178 | 98 | 5 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 180 | 98 | 5 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.87e-05 | 180 | 98 | 5 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 180 | 98 | 5 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.87e-05 | 180 | 98 | 5 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-05 | 181 | 98 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 181 | 98 | 5 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 182 | 98 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 182 | 98 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 183 | 98 | 5 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 183 | 98 | 5 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | RSV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 5.41e-05 | 184 | 98 | 5 | 1e282d619ef8035437fabe0fd2aefda1c142f7f6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | RSV-Healthy-5|RSV / Virus stimulation, Condition and Cluster | 5.41e-05 | 184 | 98 | 5 | ba958f731de6c9eff60103d483e020e2c0c7af7c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.41e-05 | 184 | 98 | 5 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.55e-05 | 185 | 98 | 5 | 76304829fcfb5934188933ca20d33bc8c8b0dc91 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.55e-05 | 185 | 98 | 5 | 0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-05 | 186 | 98 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-05 | 186 | 98 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-05 | 187 | 98 | 5 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 5.99e-05 | 188 | 98 | 5 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.99e-05 | 188 | 98 | 5 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.99e-05 | 188 | 98 | 5 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 190 | 98 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 190 | 98 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 190 | 98 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 190 | 98 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 190 | 98 | 5 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 191 | 98 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 191 | 98 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 6.78e-05 | 193 | 98 | 5 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.78e-05 | 193 | 98 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 194 | 98 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 194 | 98 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.12e-05 | 195 | 98 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 195 | 98 | 5 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 195 | 98 | 5 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.12e-05 | 195 | 98 | 5 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 196 | 98 | 5 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 196 | 98 | 5 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 196 | 98 | 5 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 196 | 98 | 5 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.47e-05 | 197 | 98 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-05 | 197 | 98 | 5 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.47e-05 | 197 | 98 | 5 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 198 | 98 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-05 | 198 | 98 | 5 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.83e-05 | 199 | 98 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 7.83e-05 | 199 | 98 | 5 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.83e-05 | 199 | 98 | 5 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.83e-05 | 199 | 98 | 5 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.83e-05 | 199 | 98 | 5 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.02e-05 | 200 | 98 | 5 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.02e-05 | 200 | 98 | 5 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 8.02e-05 | 200 | 98 | 5 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | 4fe3b2d80c567c18621bff3341f9a73578c81621 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 98 | 5 | bfbd2ccf4b28901aad63d70a382a8247e4458ba6 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-04 | 116 | 98 | 4 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 136 | 98 | 4 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 137 | 98 | 4 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-04 | 144 | 98 | 4 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | IIF-Lymphocyte-T_NK-dnT|IIF / Disease, Lineage and Cell Type | 3.03e-04 | 146 | 98 | 4 | d0f361662db5f7be26104346e8431f7e30c5ce3a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-04 | 149 | 98 | 4 | 4b44108c40376a6b73258df40d2424e68f991383 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.53e-04 | 152 | 98 | 4 | 18194f757d319958f26e5a91f56d89f25711236f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 3.53e-04 | 152 | 98 | 4 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.62e-04 | 153 | 98 | 4 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.62e-04 | 153 | 98 | 4 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.76e-05 | 22 | 95 | 3 | EFO_0009312 | |
| Disease | total blood protein measurement | 1.03e-04 | 449 | 95 | 8 | EFO_0004536 | |
| Disease | beverage consumption measurement | 1.52e-04 | 83 | 95 | 4 | EFO_0010088 | |
| Disease | atrial fibrillation | 2.01e-04 | 371 | 95 | 7 | EFO_0000275 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.49e-04 | 103 | 95 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.64e-04 | 291 | 95 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.81e-04 | 200 | 95 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 5.54e-04 | 11 | 95 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | triglycerides in medium VLDL measurement | 7.51e-04 | 55 | 95 | 3 | EFO_0022155 | |
| Disease | triglycerides in large VLDL measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0022178 | |
| Disease | triglycerides in small VLDL measurement | 1.02e-03 | 61 | 95 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.02e-03 | 61 | 95 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022299 | |
| Disease | cholesterol in large VLDL measurement | 1.22e-03 | 65 | 95 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.22e-03 | 65 | 95 | 3 | EFO_0022230 | |
| Disease | total lipids in small VLDL | 1.33e-03 | 67 | 95 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 1.33e-03 | 67 | 95 | 3 | EFO_0022175 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.33e-03 | 67 | 95 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | glaucoma (implicated_via_orthology) | 1.35e-03 | 17 | 95 | 2 | DOID:1686 (implicated_via_orthology) | |
| Disease | free cholesterol in large VLDL measurement | 1.39e-03 | 68 | 95 | 3 | EFO_0022265 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.66e-03 | 264 | 95 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | ovulation | 1.69e-03 | 19 | 95 | 2 | GO_0030728 | |
| Disease | DDT metabolite measurement | 1.78e-03 | 74 | 95 | 3 | EFO_0007886 | |
| Disease | progression free survival, ovarian serous carcinoma | 2.27e-03 | 22 | 95 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.93e-03 | 301 | 95 | 5 | DOID:684 (is_marker_for) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.17e-03 | 26 | 95 | 2 | DOID:234 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 3.17e-03 | 26 | 95 | 2 | OBA_2045191 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.20e-03 | 91 | 95 | 3 | EFO_0004611, EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HILLFLLNNSTNQNK | 1156 | Q9BXT4 | |
| HDQSFQAALQFLTLF | 1171 | Q14146 | |
| LQEHFSNQDLVFLLL | 121 | Q6UWZ7 | |
| ALTIQLFSQLFHFIN | 781 | P55196 | |
| QITEHNNFRTFFQAL | 1731 | O00555 | |
| VLDDHTQTLFQANLF | 441 | Q9BZE9 | |
| SEFSHQNLNLNTLSL | 281 | P20813 | |
| FHLVSQFIQNRIQAI | 536 | Q9N2J8 | |
| LTRLNQQAHQLAFDS | 571 | P83436 | |
| NFTHGNFTQDQLTLL | 2356 | Q8IZF6 | |
| FDVAFLTHLLNQEQL | 2181 | Q86UQ4 | |
| LTHLLNQEQLTNFSV | 2186 | Q86UQ4 | |
| LLVLHNQLSFVNQTF | 3696 | Q86UQ4 | |
| IDSFHNLSFTEQIQQ | 1206 | Q9ULJ7 | |
| NINFSLSEALHAQSL | 496 | Q5JTW2 | |
| FILNTENNFTLTDNH | 516 | P33151 | |
| NILNALSLFENINYH | 2221 | Q5H9R4 | |
| ILNCQVHSNFLNLFQ | 226 | Q5T9G4 | |
| QLFRTLFSVINNSHN | 166 | Q29RF7 | |
| QFLLNFAILGTHNIT | 891 | Q9NVH2 | |
| TLQQEQTRHLYFLQL | 116 | P26045 | |
| QISQLLSLLHQGQFQ | 961 | Q9NPG4 | |
| ANNHSALQNNLIFFT | 2451 | Q5T1H1 | |
| FQNLTSLVVLHLHNN | 206 | Q9HBX8 | |
| LQLLTHTFNREFSQV | 1586 | O60333 | |
| TAFTSQQLLELEHQF | 246 | P50219 | |
| TCLINNLHLQFVTFV | 436 | O75387 | |
| NDLQTQLFNFLIIHS | 151 | Q8IY21 | |
| QNQAILKHLLENTTF | 196 | P0DPD6 | |
| FLRSIDQFANLVLHQ | 31 | O15116 | |
| NLLNSKSFLINFIHT | 1321 | O15031 | |
| LLQNNTLTELRFHNQ | 411 | P29536 | |
| TLKHLVLQFLQQSNL | 276 | Q9H1B4 | |
| QQAFLSVQALLHNSS | 1146 | O60449 | |
| FLSHNLQKFSRAQEQ | 871 | Q9UBG0 | |
| LHQLVLNETQFSAFR | 76 | Q96KN4 | |
| QIQLSAQRSHTLEFQ | 231 | Q96KN1 | |
| VLESQFSQLLHQINS | 536 | Q9UGJ1 | |
| RNLFLTNLDNLHENN | 1191 | P00451 | |
| NLLLFHRQNVSSFQS | 141 | Q6JVE6 | |
| LSQIFADLHQQNQLS | 256 | Q96KD3 | |
| HDFILLNTDLTQNVQ | 1691 | Q9C091 | |
| AAQLHRTTNFFIDNI | 96 | Q05925 | |
| RFAHLLNQSQQDFLA | 856 | Q86VI3 | |
| ITLLIASYINNFHQQ | 1436 | Q8IVE3 | |
| FILATQSAQAFLDQH | 3826 | Q9UPN3 | |
| TTLQALHGFFQQLQS | 1211 | Q5TIA1 | |
| SNQAEHQNLLFVLFL | 31 | Q8NGQ3 | |
| SVATKLNFFIHNLAQ | 1326 | O00750 | |
| FFLQHLALINLGNST | 61 | Q8NGP2 | |
| FLRLAFLQLHHQQQS | 16 | B2RXH4 | |
| HLNTQQLTAFQLLFA | 501 | Q01780 | |
| NFTSQLSSQVEQFLH | 4431 | P04114 | |
| VNFDVFLQHNNTKLA | 231 | P07333 | |
| FITQDSLQLEQFSHA | 1036 | Q92608 | |
| QNNLEELFHLLNFLT | 916 | Q12873 | |
| VLKLSQEFAQLNHFT | 86 | Q5VVM6 | |
| LLRDVFHTTVNFINQ | 166 | P55957 | |
| FLQSSASVQNHEFLL | 941 | Q8WYP5 | |
| HIQTSQQALQFTDFV | 251 | Q6PJP8 | |
| QLASHSLLFQNAFAQ | 66 | P22304 | |
| VLTFQENLIQTHSQL | 361 | Q49AJ0 | |
| QNNLEELFHLLNFLT | 906 | Q14839 | |
| NALIHQLTTFQFEGQ | 1906 | Q8IVF4 | |
| LQHLGNNVFLLQTLF | 371 | Q6T423 | |
| FSIHQVNQSLGLFLA | 176 | Q6AZY7 | |
| SQLQAQTKAFEFLNH | 41 | P0C7I6 | |
| LNQLNNAATILVFFT | 101 | Q9NZG7 | |
| SALRFLNLSHNQVQD | 186 | Q8N1F8 | |
| INRQSISNFHVLLLQ | 546 | Q8N3X1 | |
| LSELSNLQELYINHN | 136 | Q9H3W5 | |
| NLQELYINHNLLSTI | 141 | Q9H3W5 | |
| DEHQTFLNKINNFSL | 271 | Q14CZ7 | |
| LFQELQEHFQALTAT | 21 | C9JCN9 | |
| NNQTQLFLEHSLLTA | 276 | Q96D42 | |
| TFDALINLQLLFLNN | 466 | Q9H156 | |
| LDLIQQSQTLFSQHT | 841 | Q9UKZ4 | |
| HFTSQQLQELEATFQ | 91 | Q99697 | |
| LVNYQESQSVIHNLL | 526 | O94855 | |
| IHQTFQLIFNILING | 231 | Q8TCG1 | |
| QLLQTLNILFENISH | 96 | Q2KHT3 | |
| LHQAQNLFKLLNLQS | 641 | P51800 | |
| FLKNSNLQHINFTRN | 111 | Q16620 | |
| ILSFHNNTSLLFINK | 156 | Q96JI7 | |
| FSEQLLNLTLSFLNN | 606 | Q96JI7 | |
| QISFSDINQVLAHQL | 221 | Q9UJT1 | |
| HLEFIQNFTNLKVLN | 576 | Q9NR97 | |
| QNFIQNLSLFLCTFL | 316 | O14980 | |
| LAFSCQQFLSQHVLQ | 116 | Q6P1L6 | |
| QQFLSQHVLQIFLGL | 121 | Q6P1L6 | |
| TFQLHLSELQLFQAE | 111 | Q6PDB4 | |
| FIQQTFLTLHQIINN | 151 | Q8NA42 | |
| INIHQNSFLVLSAAL | 81 | Q5VVC0 | |
| FLNQFLEQETHLFSA | 116 | Q6NUQ1 | |
| HFDLQFNISQVSIQA | 386 | Q5T4T6 | |
| RQAQENATLLFNIHL | 1031 | P24928 | |
| LFDFQQLTKQLHVTN | 186 | Q96NL6 | |
| QHLLILQAQFASSLF | 851 | Q9NRE2 | |
| RQLQQHDFTSQIFSL | 651 | Q04726 | |
| INLHNFSNSVLETLN | 81 | Q9HC78 | |
| AVKFNSDQLNHLFVL | 501 | Q9UPU5 | |
| FTFQLHLSDLQLFQA | 111 | Q3MIS6 | |
| QALSTSFHQQSLLQA | 911 | Q9UL36 | |
| IILHLSNGSVQINFF | 521 | P53350 | |
| HKLDSFTQVFANQNL | 141 | Q96PN7 |